Laurence Turner MP: written questions
4 Jul 2025–3 Jul 2026
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Read what this MP said, asked and contributed in Parliament.
13 published records · newest first.
Written questions
Latex: AllergiesDepartment of Health and Social CareTabled 9 Jun 2026AnsweredUIN 8402More
Question: To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the impact of latex glove usage in the food industry on individuals with a latex allergy.
Answer: The Food Standards Agency recognises that the use of natural rubber latex (NRL) gloves in the food industry may pose a risk to individuals with a latex allergy, with reactions ranging from mild irritation to, in rare cases, severe allergic responses. Unde...
Answered 1 Jul 2026
Original Parliament recordFriedreich's Ataxia: Health ServicesDepartment of Health and Social CareTabled 13 May 2026AnsweredUIN 676More
Question: To ask the Secretary of State for Health and Social Care, with reference to the oral contribution of the Deputy Prime Minister, on 05 November 2025, Official Report, column 903, what recent progress his Department has made on ensuring that the NHS support
Answer: Following the oral question, the former Parliamentary Under-Secretary of State for Health Innovation and Safety met with Jonathan Brash, his constituent, and Ataxia UK. Under the UK Rare Diseases Framework, the Government is working to improve access to s...
Answered 20 May 2026
Original Parliament recordHydrocortisoneDepartment of Health and Social CareTabled 14 Apr 2026AnsweredUIN 127384More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact on patients with (a) Addison's Disease and (b) adrenal insufficiency of the permanent discontinuation of hydrocortisone sodium phosphate 100mg/1m
Answer: The Department are aware of the discontinuation of hydrocortisone sodium phosphate 100 milligram/one millilitre solution for injection and we continue to work with industry to find a longer-term solution.Hydrocortisone sodium succinate 100 milligram powde...
Answered 21 Apr 2026
Original Parliament recordCare Homes: BirminghamDepartment of Health and Social CareTabled 6 Mar 2026AnsweredUIN 118615More
Question: To ask the Secretary of State for Health and Social Care, when the Bryony House care home in Birmingham Northfield constituency will next be inspected by the CQC.
Answer: Bryony House Care Home was last inspected by the Care Quality Commission (CQC) in May 2025 and was rated as Inadequate and placed into special measures.The CQC has advised that it continues to monitor the service closely and will carry out a further asses...
Answered 11 Mar 2026
Original Parliament recordVaccine Damage Payment SchemeDepartment of Health and Social CareTabled 9 Feb 2026AnsweredUIN 111976More
Question: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 17 November 2025 to Question 86092, how many claimants were awarded a payment under the Vaccine Damage Payments Scheme in each financial year since 2021-22.
Answer: The NHS Business Services Authority is the administrator of the Vaccine Damage Payment Scheme (VDPS). The following table shows the total number of awarded claims in each financial year since 2021/22:YearTotal number of VDPS claims awarded2021/2212022/237...
Answered 16 Feb 2026
Original Parliament recordLatex: AllergiesDepartment of Health and Social CareTabled 3 Feb 2026AnsweredUIN 110591More
Question: To ask the Secretary of State for Health and Social Care, with reference to the Answer of 15 January to Question 101203, on Latex: Allergies, if he will place a copy of the Expert Advisory Group on Allergy's December 2025 minutes in the House of Commons L
Answer: The Terms of Reference for the Expert Advisory Group on Allergy, which is overseen and supported by external stakeholders, states that the meetings are confidential. Therefore, the meeting minutes are not shared publicly.
Answered 6 Feb 2026
Original Parliament recordLatex: AllergiesDepartment of Health and Social CareTabled 17 Dec 2025AnsweredUIN 101203More
Question: To ask the Secretary of State for Health and Social Care, whether he will make an assessment of the potential merits of measures in the Rhode Island Latex Gloves Safety Act 2024 to help prevent latex allergy harm in England.
Answer: The Department is working closely with a range of stakeholders across the Government, the National Health Service, voluntary organisations, and patient representative groups to consider how allergy care and support could be improved.The Expert Advisory Gr...
Answered 15 Jan 2026
Original Parliament recordVaccination: CompensationDepartment of Health and Social CareTabled 28 Oct 2025AnsweredUIN 86094More
Question: To ask the Secretary of State for Health and Social Care, whether his Department's Vaccine Damage Payment Unit is still in operation.
Answer: The Vaccine Damage Payment Scheme (VDPS) provides a one-off, tax-free payment of £120,000 to claimants who have been found, in rare cases and on the balance of probabilities, to have been severely disabled by certain vaccines for a disease listed in the V...
Answered 4 Nov 2025
Original Parliament recordVaccine Damage Payment SchemeDepartment of Health and Social CareTabled 28 Oct 2025AnsweredUIN 86092More
Question: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 28 October 2025 to Question 83545 on Vaccine Damage Payment Scheme, if he will publish a version of the table provided for the years prior to 2021-22.
Answer: The information requested is not held by the Department of Health and Social Care as the Vaccine Damage Payment Scheme was administered by the Department for Work and Pensions until 2021.
Answered 4 Nov 2025
Original Parliament recordVaccine Damage Payment SchemeDepartment of Health and Social CareTabled 20 Oct 2025AnsweredUIN 83545More
Question: To ask the Secretary of State for Health and Social Care, what the total amount of payment is through the Vaccine Damage Payments Scheme; and how much has been paid in each year for which figures are available.
Answer: The Vaccine Damage Payment Scheme provides a one-off, tax-free payment of £120,000 to claimants who have been found, in rare cases and on the balance of probabilities, to have been severely disabled, 60% or more, by certain vaccines for a disease listed i...
Answered 28 Oct 2025
Original Parliament recordPrimodos: ResearchDepartment of Health and Social CareTabled 2 Sept 2025AnsweredUIN 74394More
Question: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 3 March 2025 to Question 31168 on Primodos: Research and with reference to the oral contribution of Mr Roland Moyle on 26 May 1978, HC official record Volume 950, whether
Answer: The review referenced in Question 31168 considered the 2023 publication by Danielsson et al only. The Medicines and Healthcare products Regulatory Agency’s (MHRA) assessment of this publication focussed on new data, which concerned transient embryonic hyp...
Answered 9 Sept 2025
Original Parliament recordAccident and Emergency Departments: StaffDepartment of Health and Social CareTabled 1 Sept 2025AnsweredUIN 73945More
Question: To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the number of Accident and Emergency intake staff.
Answer: The 10-Year Workforce Plan, which will be published later this year, will ensure the NHS has the right people, in the right places, including in vital services such as Accident and Emergency, with the right skills to care for patients when they need it.
Answered 8 Sept 2025
Original Parliament recordTirzepatideDepartment of Health and Social CareTabled 1 Sept 2025AnsweredUIN 73912More
Question: To ask the Secretary of State for Health and Social Care, with reference to NHS England’s publication entitled Interim commissioning guidance: Implementation of the NICE Technology Appraisal TA1026 and the NICE funding variation for tirzepatide (Mounjaro)
Answer: The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing evidence-based guidance for the National Health Service on the use of licensed medicines based on an assessment of their clinical and cost-effe...
Answered 9 Sept 2025
Original Parliament record
Explore activity by topic or department
Written questions by answering department
4 Jul 2025–3 Jul 2026. One record per UIN and tabled date; the named department is not a measure of answer quality.
View as listWhat this shows and doesn't show
Published records only — not a full account of an MP’s work. How we work →